V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031355 | 20143175 | 1.6 | 65.4 | Adjuvant (A) | null | 2016-11-13 | FEC 100 + DOCETAXEL | N | N | 20110372 | FEC + DOCETAXEL |
| 20031356 | 20013379 | null | 91.8 | Neo-adjuvant (N) | 2015-09-30 | 2015-10-30 | FEC 100 + DOCETAXEL | N | null | 20110375 | FEC + DOCETAXEL |
| 20031357 | 20013379 | 1.57 | 70.18 | Adjuvant (A) | 2018-03-05 | 2018-03-06 | FEC + DOCETAXEL | 02 | N | 20110375 | FEC + DOCETAXEL |
| 20031358 | 20013380 | 1.7 | null | Adjuvant (A) | null | 2017-08-31 | FEC 100 + DOCETAXEL | null | N | 20110379 | FEC + DOCETAXEL |
| 20031359 | 20013380 | 1.56 | 63 | Adjuvant (A) | 2014-02-15 | 2014-02-24 | FEC 100 + DOCETAXEL | 2 | N | 20110379 | FEC + DOCETAXEL |
| 20031360 | 20013381 | 1.67 | 102 | Curative (C) | 2015-08-15 | 2015-08-15 | FEC + DOCETAXEL | 02 | null | 20110388 | FEC + DOCETAXEL |
| 20031361 | 20013381 | 1.68 | 87.1 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-11 | FEC + DOCETAXEL | N | null | 20110388 | FEC + DOCETAXEL |
| 20031362 | 20013381 | 1.6 | 54.7 | Neo-adjuvant (N) | 2014-07-06 | 2014-07-06 | FEC 100 + DOCETAXEL | 2 | N | 20110388 | FEC + DOCETAXEL |
| 20031363 | 20013381 | 1.75 | 110.2 | Disease modification (D) | 2014-07-15 | 2014-07-15 | FEC + DOCETAXEL | 02 | null | 20110388 | FEC + DOCETAXEL |
| 20031364 | 20013381 | 1.51 | 81.4 | Adjuvant (A) | 2013-06-08 | 2013-06-16 | FEC + DOCETAXEL | N | N | 20110388 | FEC + DOCETAXEL |
| 20031365 | 20013382 | 1.62 | 74 | Neo-adjuvant (N) | 2015-07-23 | 2015-07-25 | FEC 100 + DOCETAXEL | N | N | 20110408 | FEC + DOCETAXEL |
| 20031366 | 20013382 | null | 61 | Adjuvant (A) | 2017-05-31 | 2017-05-31 | FEC + DOCETAXEL | N | null | 20110408 | FEC + DOCETAXEL |
| 20031367 | 20013382 | 1.58 | 69 | Adjuvant (A) | 2016-04-26 | 2016-05-13 | FEC + DOCETAXEL | 2 | N | 20110408 | FEC + DOCETAXEL |
| 20031368 | 20013383 | null | null | Adjuvant (A) | 2013-04-02 | 2013-04-11 | FEC 100 + DOCETAXEL | N | N | 20110416 | FEC + DOCETAXEL |
| 20031369 | 20013383 | 1.61 | null | Adjuvant (A) | 2013-04-25 | 2013-05-02 | FEC 100 + DOCETAXEL | N | N | 20110416 | FEC + DOCETAXEL |
| 20031370 | 20013384 | 1.62 | 85.8 | Adjuvant (A) | 2016-06-17 | 2016-07-05 | FEC + DOCETAXEL | 2 | N | 20110428 | FEC + DOCETAXEL |
| 20031371 | 20013385 | null | null | Adjuvant (A) | 2017-06-13 | 2017-08-10 | FEC + DOCETAXEL | N | N | 20110437 | FEC + DOCETAXEL |
| 20031372 | 20013386 | 1.57 | 58.4 | Adjuvant (A) | 2013-10-03 | 2013-10-18 | FEC 100 + DOCETAXEL | 02 | null | 20110448 | FEC + DOCETAXEL |
| 20031373 | 20073152 | 1.67 | 73 | Adjuvant (A) | 2016-04-24 | 2016-05-06 | FEC + DOCETAXEL | 02 | N | 20110456 | FEC + DOCETAXEL |
| 20031374 | 20073152 | 1.64 | 58.1 | Neo-adjuvant (N) | 2014-06-25 | 2014-07-09 | FEC 100 + DOCETAXEL | 02 | N | 20110456 | FEC + DOCETAXEL |
| 20031375 | 20013387 | 1.59 | 61 | Adjuvant (A) | 2013-04-11 | 2013-04-11 | FEC + DOCETAXEL | 2 | N | 20110488 | FEC + DOCETAXEL |
| 20031376 | 20073153 | 1.73 | 62.1 | Adjuvant (A) | 2015-12-11 | 2015-12-14 | FEC + DOCETAXEL | 02 | N | 20110493 | FEC + DOCETAXEL |
| 20031377 | 20073153 | 1.67 | 65.8 | null | 2015-09-07 | 2015-09-07 | FEC + DOCETAXEL | 02 | N | 20110493 | FEC + DOCETAXEL |
| 20031378 | 20013388 | 1.66 | 126 | Adjuvant (A) | null | 2018-03-02 | FEC + DOCETAXEL | N | N | 20110499 | FEC + DOCETAXEL |
| 20031379 | 20013388 | 0 | 96.7 | Adjuvant (A) | 2013-10-03 | 2013-10-19 | FEC 100 + DOCETAXEL | N | N | 20110499 | FEC + DOCETAXEL |
| 20031380 | 20013389 | 1.68 | 53 | Curative (C) | 2015-12-11 | 2015-12-12 | FEC + DOCETAXEL | 02 | N | 20110515 | FEC + DOCETAXEL |
| 20031381 | 20013390 | 1.68 | 61 | Curative (C) | 2013-12-07 | 2013-12-21 | FEC + DOCETAXEL | 02 | Y | 20110519 | FEC + DOCETAXEL |
| 20031382 | 20013390 | 1.62 | null | Neo-adjuvant (N) | 2016-03-09 | 2016-03-09 | FEC + DOCETAXEL | N | null | 20110519 | FEC + DOCETAXEL |
| 20031383 | 20013390 | 1.74 | 72.3 | Neo-adjuvant (N) | 2017-02-27 | 2017-03-09 | FEC + DOCETAXEL | 02 | N | 20110519 | FEC + DOCETAXEL |
| 20031384 | 20013391 | 1.6 | 58.4 | Curative (C) | 2016-08-24 | 2016-08-24 | FEC + DOCETAXEL | 02 | N | 20110538 | FEC + DOCETAXEL |
| 20031385 | 20013392 | 1.66 | 59.2 | Adjuvant (A) | 2014-12-12 | 2015-01-03 | FEC 100 + DOCETAXEL | N | N | 20110543 | FEC + DOCETAXEL |
| 20031386 | 20013392 | 1.71 | 94.6 | Neo-adjuvant (N) | 2017-09-01 | 2017-09-16 | FEC 100 + DOCETAXEL | N | N | 20110543 | FEC + DOCETAXEL |
| 20031387 | 20013393 | null | null | Adjuvant (A) | 2018-03-27 | 2018-03-28 | FEC 100 + DOCETAXEL | N | N | 20110550 | FEC + DOCETAXEL |
| 20031388 | 20013394 | 1.6 | 76.5 | Neo-adjuvant (N) | 2018-01-28 | 2018-01-31 | FEC + DOCETAXEL | 02 | N | 20110551 | FEC + DOCETAXEL |
| 20031389 | 20013394 | null | null | Adjuvant (A) | 2017-04-28 | 2017-05-21 | FEC 100 + DOCETAXEL | N | N | 20110551 | FEC + DOCETAXEL |
| 20031390 | 20013394 | 1.76 | 106 | Adjuvant (A) | 2017-03-02 | 2017-03-07 | FEC 100 + DOCETAXEL | 2 | N | 20110551 | FEC + DOCETAXEL |
| 20031391 | 20013394 | 1.66 | 62.3 | Curative (C) | 2017-01-01 | 2017-01-01 | FEC + DOCETAXEL | 02 | N | 20110551 | FEC + DOCETAXEL |
| 20031392 | 20013395 | 1.73 | 56 | Curative (C) | 2015-05-19 | 2015-06-04 | FEC + DOCETAXEL | 2 | N | 20110563 | FEC + DOCETAXEL |
| 20031393 | 20013396 | 1.67 | null | null | 2017-01-11 | 2017-01-31 | FEC + DOCETAXEL | 99 | N | 20110565 | FEC + DOCETAXEL |
| 20031394 | 20013397 | null | 90.65 | null | 2014-10-03 | 2014-10-28 | FEC + DOCETAXEL | N | N | 20110574 | FEC + DOCETAXEL |
| 20031395 | 20013397 | null | 82.4 | Adjuvant (A) | 2014-08-23 | 2014-09-05 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20110574 | FEC + DOCETAXEL |
| 20031396 | 20013398 | 1.79 | 56.3 | Neo-adjuvant (N) | 2016-05-18 | 2016-05-18 | FEC + DOCETAXEL | 2 | N | 20110580 | FEC + DOCETAXEL |
| 20031397 | 20013398 | 1.67 | 80.7 | Adjuvant (A) | 2014-02-06 | 2014-02-06 | FEC + DOCETAXEL | 02 | N | 20110580 | FEC + DOCETAXEL |
| 20031398 | 20013398 | 1.61 | 72.9 | Adjuvant (A) | 2017-02-20 | 2017-02-28 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20110580 | FEC + DOCETAXEL |
| 20031399 | 20013398 | 1.61 | 86.9 | Adjuvant (A) | 2015-01-02 | 2015-01-17 | FEC + DOCETAXEL | Y | N | 20110580 | FEC + DOCETAXEL |
| 20031400 | 20013399 | 1.67 | 51 | Adjuvant (A) | 2013-10-25 | 2013-10-25 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20110589 | FEC + DOCETAXEL |
| 20031401 | 20013399 | 1.58 | 63.6 | Adjuvant (A) | 2014-02-25 | 2014-03-04 | FEC + DOCETAXEL | 02 | N | 20110589 | FEC + DOCETAXEL |
| 20031402 | 20013399 | 1.6 | 87 | Adjuvant (A) | 2015-06-19 | 2015-06-19 | FEC + DOCETAXEL | 02 | N | 20110589 | FEC + DOCETAXEL |
| 20031403 | 20013399 | 1.72 | 130.9 | Neo-adjuvant (N) | 2014-08-30 | 2014-08-30 | FEC 100 + DOCETAXEL | N | N | 20110589 | FEC + DOCETAXEL |
| 20031404 | 20013399 | 1.57 | 50 | Not known (9) | null | 2014-06-02 | FEC 100 + DOCETAXEL | N | N | 20110589 | FEC + DOCETAXEL |